Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors-Reference-Cited by-同舟云学术

Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors

Published:2017-11-22 Issue:1 Volume:5 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Hansen Janne Fuglsang¹²,Hallager Sofie³,Øvrehus Anne¹²,Weis Nina³⁴,Brehm Christensen Peer¹²,Pedersen Court¹²

Affiliation:

1. Department of Infectious Diseases, Odense University Hospital, Denmark

2. Clinical Institute, University of Southern Denmark, Odense

3. Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark

4. Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Denmark

Abstract

Abstract Patients with chronic hepatitis C may have advanced fibrosis at first evaluation. Using the European Association for the Study of the Liver (EASL) definition (FibroScan® >9.5 kPa) for “late presenter for care” (LP), we found that 32% (169 of 527) of patients were LP. Being a LP was associated with increasing age and a history of alcohol overuse.

Funder

Region of Southern Denmark

Gilead Sciences Nordic Fellowship Programme 2014

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/1/ofx257/33576903/ofx257.pdf

Reference15 articles.

2. EASL recommendations on treatment of Hepatitis C 2016;EASL,2016

3. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents;Lin;Aliment Pharmacol Ther,2017